U.S. markets closed

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.66-0.14 (-1.09%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Premium required to access quarterly data
Quarterly
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
2,140
0
0
0
0
Operating Expense
135,359
129,041
89,286
60,968
30,391
Operating Income
-133,219
-129,041
-89,286
-60,968
-30,391
Other Income Expense
6,383
6,594
3,998
847
100.141
Pretax Income
-130,038
-122,447
-85,288
-60,121
-30,291
Net Income Common Stockholders
-130,038
-122,447
-85,288
-64,878
-34,696
Diluted NI Available to Com Stockholders
-130,038
-122,447
-85,288
-64,878
-34,696
Basic EPS
-
-0.0033
-0.0026
-0.0036
-0.0016
Diluted EPS
-
-0.0033
-0.0026
-0.0036
-0.0016
Basic Average Shares
-
37,499
33,317
18,198
18,549
Diluted Average Shares
-
37,499
33,317
18,198
18,549
Total Operating Income as Reported
-133,219
-129,041
-89,286
-60,968
-30,391
Total Expenses
135,359
129,041
89,286
60,968
30,391
Net Income from Continuing & Discontinued Operation
-130,038
-122,447
-85,288
-60,121
-30,291
Normalized Income
-130,038
-122,447
-85,288
-60,080
-30,209
EBIT
-136,367
-129,041
-89,286
-60,968
-30,391
EBITDA
-135,823
-
-
-
-
Reconciled Depreciation
544
356
175
89
67.226
Net Income from Continuing Operation Net Minority Interest
-130,038
-122,447
-85,288
-60,121
-30,291
Total Unusual Items Excluding Goodwill
-
-
-
-41
-82.231
Total Unusual Items
-
-
-
-41
-82.231
Normalized EBITDA
-135,823
-128,685
-89,111
-60,838
-30,241
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0